Forest Laboratories News

News on Forest Laboratories (Ticker: FRX) continually updated from thousands of sources around the net.

Friday May 25 | Seeking Alpha

Forest Laboratories (FRX) says it's decided to discontinue the...

Forest Laboratories says it's decided to discontinue the development of apadenoson, its experimental agent for cardiovascular imaging procedures.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Forest Labs

Tue May 08, 2012

Seeking Alpha

Why Billionaire Carl Icahn Could Target This Substantially Undervalued Biotech

Billionaire activist investor Carl Icahn has made a fortune off of targeting declining biotech companies.

Comment?

Fri May 04, 2012

Freshnews

Forest Laboratories, Inc. to Present Cariprazine and Levomilnacipran...

Forest Laboratories, Inc. to Present Cariprazine and Levomilnacipran Results from Phase 3 Trials at American Psychiatric Association Annual Meeting NEW YORK -- -- Forest Laboratories, Inc.

Comment?

Related Topix: Biotech, Medicine, Forest Labs, Healthcare Industry

Wed May 02, 2012

Reuters

UPDATE 1-Lundbeck keeps year outlook after Q1 lags forecasts

Danish drugmaker Lundbeck stood by its forecasts for 2012 on Wednesday despite a disappointing first quarter, when sales of its leading drug fell more sharply than expected as it loses patent protection.

Comment?

Mon Apr 30, 2012

AmericanBankingNews.com

Forest Laboratories Given "Neutral" Rating at Zacks

's stock had its "neutral" rating restated by Zacks in a report issued on Monday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Forest Labs